Fatty Liver Disease and Overweight
NOW RECRUITING
-
Adelaide SA
A study to investigate the effect of a new medication in adults with Fatty Liver Disease and Obesity who are at risk of developing worsening liver disease.
- Age > 18 years
- BMI ≥ 25kg/m2
- Not taking Ozempic/Mounjaro
- Weekly self-injection
- Elevated Liver Fat content - assessed at screening
- No history of surgical treatment for obesity (some exceptions)
- Not diabetic type 1
Outpatient Visit
- Screening visit (part 1 and part 2)
- Monthly clinic visits for 6 months
- Then clinic visits every 2 months
Payment / Remuneration
- Reimbursed for travel $75 per visit
- Reimbursment for meals at fasting visits $48
Information for Practitioners
- Screening bloods
- Liver fat content ≥8% (on MRI)
- VCTE-LSM ≥10<20kPa (on Fibroscan) - assessed at screening visit
- Fundus photography for diabetic participants
- No history of liver cirrhosis
- Exclusion - alcohol intake >21 units/week (males) or >14 units/week (females)
- No history of cancers >5 years prior to screening (some exceptions)
Loading...